CAT
Caterpillar Inc.
CAT has the edge over SNDR overall, supported by stronger fundamentals and stronger valuation.
SNDR
Schneider National, Inc.
SNDR has slightly lower modeled downside risk, despite its lower overall score.
CAT Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| Strong | |
| Strong |
CAT's revenue, profitability, cash flow and balance sheet are all currently healthy.
SNDR Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Healthy | |
| Stable | |
| Strong |
SNDR's revenue, profitability and balance sheet are currently healthy, and its cash flow is stable.
CAT PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 15x | $380 | -37% |
| Fair | 18x | $461 | -24% |
| Forward | 20x | $605 | — |
| Current | 24x | $605 | — |
| Expensive | 33x | $840 | +39% |
Historical ranges are pointers, not guarantees.
CAT has the edge over SNDR in the historical PE scenario, which offers more potential upside but is not a forecast.
SNDR PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 11x | $8.73 | -70% |
| Forward | 19x | $28.95 | — |
| Fair | 21x | $17.28 | -40% |
| Current | 36x | $28.95 | — |
| Expensive | 42x | $33.96 | +17% |
Historical ranges are pointers, not guarantees.
SNDR's PE is in its expensive range at 36x. If earnings grow as analysts expect, today's price would be 19x next year's earnings, in its fair range.
CAT Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Strong growth | |
| Growth | |
| Strongly improving | |
| Moderate | |
| Low |
Analysts expect earnings and revenue growth for CAT, with profitability improving. However, they disagree widely on these estimates.
SNDR Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| Low |
Analysts expect earnings and revenue growth for SNDR, with profitability improving. However, they disagree widely on these estimates.
CAT Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $30.32 | +19% |
| Q3 2026 | $25.48 | +31% |
| Q2 2026 | $23.23 | +18% |
| Q1 2026 | $20.08 | -2% |
| Q4 2025 | $18.81 | -15% |
| Q3 2025 | $19.46 | -9.7% |
| Q2 2025 | $19.64 | -10% |
| Q1 2025 | $20.50 | -7.4% |
| Q4 2024 | $22.05 | +9.6% |
CAT has the edge over SNDR on earnings, with stronger typical year-over-year growth.
SNDR Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $1.49 | +84% |
| Q3 2026 | $0.81 | +25% |
| Q2 2026 | $0.64 | -9.9% |
| Q1 2026 | $0.56 | -21% |
| Q4 2025 | $0.59 | -11% |
| Q3 2025 | $0.65 | +3.2% |
| Q2 2025 | $0.71 | +7.6% |
| Q1 2025 | $0.71 | -20% |
| Q4 2024 | $0.66 | -51% |
SNDR's earnings per share have fallen from their peak: $0.81 over the past year, against $2.70 in late 2022.
CAT Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $20.7B | +17% |
| Q2 2026 | $20.5B | +24% |
| Q1 2026 | $17.4B | +22% |
| Q4 2025 | $19.1B | +18% |
| Q3 2025 | $17.6B | +9.5% |
| Q2 2025 | $16.6B | -0.7% |
| Q1 2025 | $14.2B | -9.8% |
| Q4 2024 | $16.2B | -5% |
CAT's revenue has grown year over year for five quarters in a row: $20.7B last quarter, up 17% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 20% | +3.1 points |
| Q2 2026 | 21% | +3.6 points |
| Q1 2026 | 18% | -0.4 points |
| Q4 2025 | 14% | -4.1 points |
| Q3 2025 | 17% | -2.2 points |
| Q2 2025 | 17% | -3.6 points |
| Q1 2025 | 18% | -4.2 points |
| Q4 2024 | 18% | -0.3 points |
CAT has the edge over SNDR on profitability, with a higher operating margin.
SNDR Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $1.6B | +9.2% |
| Q2 2026 | $1.6B | +10% |
| Q1 2026 | $1.4B | -0.2% |
| Q4 2025 | $1.4B | +4.5% |
| Q3 2025 | $1.5B | +10% |
| Q2 2025 | $1.4B | +7.9% |
| Q1 2025 | $1.4B | +6.3% |
| Q4 2024 | $1.3B | -2.4% |
SNDR's revenue has picked up after two years of holding roughly level: $1.6B last quarter, up 9.2% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 3.9% | +1.5 points |
| Q2 2026 | 4.5% | +0.7 points |
| Q1 2026 | 2.4% | -0.6 points |
| Q4 2025 | 2.6% | -0.6 points |
| Q3 2025 | 2.4% | -0.8 points |
| Q2 2025 | 3.9% | 0 points |
| Q1 2025 | 3% | +0.8 points |
| Q4 2024 | 3.2% | +0.9 points |
SNDR's operating margin was 3.9% last quarter, up 1.5 points from the same quarter a year ago.
CAT Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $3.7B | +19% |
| Q2 2026 | $3.8B | +47% |
| Q1 2026 | $1.1B | +97% |
| Q4 2025 | $2.7B | +0.1% |
| Q3 2025 | $3.1B | -1.5% |
| Q2 2025 | $2.6B | -4.2% |
| Q1 2025 | $579M | -63% |
| Q4 2024 | $2.7B | -22% |
CAT generated $11.3B in free cash flow over the past year, up 26% from the year before.
SNDR Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $2.3M | -96% |
| Q2 2026 | $58.6M | -45% |
| Q1 2026 | $52M | +$74.7M |
| Q4 2025 | $145.5M | +28% |
| Q3 2025 | $56.2M | -43% |
| Q2 2025 | $106.4M | +24% |
| Q1 2025 | -$22.7M | +$3M |
| Q4 2024 | $113.6M | +230% |
SNDR has the edge over CAT on cash flow, with more consistent year-over-year improvement.
CAT Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.3% | -1.6M shares |
| 1 year | -2.1% | -9.9M shares |
| 3 years | -10% | -51.7M shares |
| 5 years | -16% | -86.7M shares |
| Available history | -19% | -107M shares |
CAT has the edge over SNDR on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $1.2B |
| Q2 2026 | $1.5B |
| Q1 2026 | $5B |
| Q4 2025 | $340M |
| Q3 2025 | $362M |
| Q2 2025 | $828M |
| Q1 2025 | $3.7B |
| Q4 2024 | $640M |
CAT spent $8.1B buying back its own shares over the past year, up 47% from the year before.
SNDR Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.2% | +300K shares |
| 1 year | +0.2% | +400K shares |
| 3 years | -0.8% | -1.4M shares |
| 5 years | -0.9% | -1.6M shares |
| Available history | -0.6% | -1M shares |
SNDR has 176M diluted shares, about the same as a year ago.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q2 2026 | — |
| Q1 2026 | $5.2M |
| Q4 2025 | $6.3M |
| Q3 2025 | — |
| Q2 2025 | — |
| Q1 2025 | $8.3M |
| Q4 2024 | — |
SNDR spent $12M buying back its own shares over the past year, up 39% from the year before.
CAT Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.5x | Net Cash |
| Q2 2026 | -0.4x | Net Cash |
| Q1 2026 | -0.3x | Net Cash |
| Q4 2025 | 2.0x | Healthy |
| Q3 2025 | -0.6x | Net Cash |
| Q2 2025 | -0.4x | Net Cash |
| Q1 2025 | -0.3x | Net Cash |
| Q4 2024 | 1.6x | Healthy |
CAT has the edge over SNDR on leverage, with a lower net debt burden relative to earnings.
SNDR Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.1x | Very low |
| Q2 2026 | 0.2x | Very low |
| Q1 2026 | 0.3x | Very low |
| Q4 2025 | 0.3x | Very low |
| Q3 2025 | 0.5x | Very low |
| Q2 2025 | 0.6x | Very low |
| Q1 2025 | 0.8x | Very low |
| Q4 2024 | 0.7x | Very low |
SNDR's net debt is less than a year of its operating earnings (EBITDA).
CAT Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 32.7 | Neutral |
| Stochastic | 6.7 | Oversold |
CAT's weekly RSI is 33 (neutral) and its Stochastic is 7 (oversold).
SNDR Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 39.5 | Neutral |
| Stochastic | 7.4 | Oversold |
SNDR's weekly RSI is 39 (neutral) and its Stochastic is 7 (oversold).
CAT PE vs Industrials Sector
| Metric | CAT | Sector median | Relative |
|---|---|---|---|
| PE | 24x | 24x | 1.3% below |
| PE % | 69 | 58 | 11 pts above |
CAT has the edge over SNDR on valuation relative to its sector.
SNDR PE vs Industrials Sector
| Metric | SNDR | Sector median | Relative |
|---|---|---|---|
| PE | 36x | 24x | 48% above |
| PE % | 77 | 58 | 19 pts above |
SNDR is trading at 36x earnings, a 48% premium to the Industrials sector's median of 24x.
CAT Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $709.0 | 15% below |
| 20 week MA | $797.0 | 24% below |
| 50 week MA | $771.3 | 22% below |
| 100 week MA | $586.7 | 3.2% above |
| 200 week MA | $443.1 | 37% above |
CAT has pulled back, but its long-term trend is still up: it's below its 8-, 20- and 50-week averages, but 37% above its 200-week average.
SNDR Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $30.4 | 4.9% below |
| 20 week MA | $33.6 | 14% below |
| 50 week MA | $31.2 | 7.2% below |
| 100 week MA | $27.9 | 3.8% above |
| 200 week MA | $27.0 | 7.1% above |
SNDR has pulled back, but its long-term trend is still up: it's below its 8-, 20- and 50-week averages, but 7.1% above its 200-week average.
CAT Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $148.3 | $179.6 | +21% |
| 2021 | $179.6 | $206.2 | +15% |
| 2022 | $206.2 | $239.9 | +16% |
| 2023 | $239.9 | $295.7 | +23% |
| 2024 | $295.7 | $364.9 | +23% |
| 2025 | $364.9 | $583.0 | +60% |
| 2026 YTD | $583.0 | $605.3 | +3.8% |
CAT has finished every year since 2020 higher, and it's up 3.8% so far in 2026.
SNDR Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $21.7 | $20.7 | -4.3% |
| 2021 | $20.7 | $26.2 | +26% |
| 2022 | $26.2 | $24.1 | -7.9% |
| 2023 | $24.1 | $25.5 | +5.6% |
| 2024 | $25.5 | $29.5 | +16% |
| 2025 | $29.5 | $27.3 | -7.6% |
| 2026 YTD | $27.3 | $29.0 | +6.1% |
SNDR has the edge over CAT on returns for 2026, with the stronger performance.